Atrys Health SL (MC:ATRY) — Market Cap & Net Worth
Market Cap & Net Worth: Atrys Health SL (ATRY)
Atrys Health SL (MC:ATRY) has a market capitalization of $214.84 Million (€183.76 Million) as of May 7, 2026. Listed on the MC stock exchange, this Spain-based company holds position #16305 globally and #106 in its home market, demonstrating a -3.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Atrys Health SL's stock price €2.81 by its total outstanding shares 75915138 (75.92 Million). Analyse Atrys Health SL (ATRY) cash conversion ratio to see how efficiently the company converts income to cash.
Atrys Health SL Market Cap History: 2016 to 2026
Atrys Health SL's market capitalization history from 2016 to 2026. Data shows growth from $120.43 Million to $249.40 Million (6.86% CAGR).
Atrys Health SL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Atrys Health SL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.41x
Atrys Health SL's market cap is 1.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $120.43 Million | $5.96 Million | $63.04K | 20.20x | 1910.29x |
| 2017 | $174.95 Million | $8.03 Million | $290.94K | 21.79x | 601.32x |
| 2018 | $245.06 Million | $7.29 Million | $11.98K | 33.60x | 20446.83x |
| 2019 | $443.76 Million | $14.84 Million | -$104.78K | 29.91x | N/A |
| 2020 | $789.90 Million | $33.81 Million | -$5.55 Million | 23.36x | N/A |
| 2021 | $900.84 Million | $121.01 Million | -$23.20 Million | 7.44x | N/A |
| 2022 | $550.27 Million | $158.37 Million | -$23.15 Million | 3.47x | N/A |
| 2023 | $325.72 Million | $201.57 Million | -$45.59 Million | 1.62x | N/A |
| 2024 | $299.10 Million | $212.74 Million | -$31.77 Million | 1.41x | N/A |
Competitor Companies of ATRY by Market Capitalization
Companies near Atrys Health SL in the global market cap rankings as of May 7, 2026.
Key companies related to Atrys Health SL by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $108.50 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #357 globally with a market cap of $74.92 Billion USD.
- UCB SA (BR:UCB): Ranked #513 globally with a market cap of $51.74 Billion USD ( €44.26 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #572 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $108.50 Billion | $427.65 |
| #357 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.92 Billion | $721.05 |
| #513 | UCB SA | BR:UCB | $51.74 Billion | €236.00 |
| #572 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
Atrys Health SL Historical Marketcap From 2016 to 2026
Between 2016 and today, Atrys Health SL's market cap moved from $120.43 Million to $ 249.40 Million, with a yearly change of 6.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €249.40 Million | -4.10% |
| 2025 | €260.05 Million | -13.06% |
| 2024 | €299.10 Million | -8.17% |
| 2023 | €325.72 Million | -40.81% |
| 2022 | €550.27 Million | -38.92% |
| 2021 | €900.84 Million | +14.04% |
| 2020 | €789.90 Million | +78.00% |
| 2019 | €443.76 Million | +81.09% |
| 2018 | €245.06 Million | +40.07% |
| 2017 | €174.95 Million | +45.27% |
| 2016 | €120.43 Million | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Atrys Health SL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $214.84 Million USD |
| MoneyControl | $214.84 Million USD |
| MarketWatch | $214.84 Million USD |
| marketcap.company | $214.84 Million USD |
| Reuters | $214.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of r… Read more